Cloning and expression of canine O6-methylguanine-DNA methyltransferase in target cells, using gammaretroviral and lentiviral vectors.
Cloning and expression of canine O6-methylguanine-DNA methyltransferase in target cells, using gammaretroviral and lentiviral vectors.
复制标题
使用γ逆转录病毒和慢病毒载体在靶细胞中克隆和表达犬O6-甲基鸟嘌呤-DNA 甲基转移酶。
DOI:
10.1089/104303404322959533
复制
发表时间:
2004
期刊:
影响因子:
--
通讯作者:
Schuening,Friedrich
中科院分区:
文献类型:
--
作者:
Zaboikin,Michail;Srinivasakumar,Narasimhachar;Zaboikina,Tatiana;Schuening,Friedrich
The humanO6-methylguanine-DNA methyltransferase (MGMT) gene and its mutants have been used forin vivoselection of transduced hematopoietic stem cells with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) alone or in combination withO6-benzylguanine (BG). To allow similarin vivoselection in dogs, without the risk of inducing an immune response, we have cloned the canine MGMT drug resistance gene. Comparison of canine and human MGMT-coding regions indicates that there is about 62% amino acid identity and 78% similarity between the two MGMTs. The canine MGMT is also longer, by nine amino acids. Proline at position 140 and the surrounding amino acids of the human MGMT are highly conserved in the canine sequence. To determine whether mutation of the proline residue at position 144 to lysine in the canine MGMT would provide a similar advantage for selection of transduced cells as the human mutant, Moloney murine leukemia virus and human immunodeficiency type 1 vectors encoding the corresponding mutant MGMT were created and used to express separately canine and human MGMTs in cultured cells. Drug resistance assays using BCNU alone or BCNU with BG demonstrated that the wild-type and mutant canine MGMTs provided resistance to the selection agents that was comparable to the human MGMT counterparts.